1. Open innovation: Towards sharing of data, models and workflows. Daniela J.Conrado, Mats O. Karlsson, Klaus Romero, Céline Sarr and Justin J.Wilkins Eur J Pharm Sci. 2017 doi: 10.1016/j.ejps.2017.06.035
  2. PharmML in Action: an Interoperable Language for Modeling and Simulation. Bizzotto R, Comets E, Smith G, Yvon F, Kristensen NR, Swat MJ. CPT: Pharmacometrics Syst Pharmacol. 2017
  3. Model Description Language (MDL): A Standard for Modeling and Simulation. Smith MK, Moodie SL, Bizzotto R, Blaudez E, Borella E, Carrara L, Chan P, Chenel M, Comets E, Gieschke R, Harling K, Harnisch L, Hartung N, Hooker AC, Karlsson MO, Kaye R, Kloft C, Kokash N, Lavielle M, Lestini G, Magni P, Mari A, Mentré F, Muselle C, Nordgren R, Nyberg HB, Parra-Guillén ZP, Pasotti L, Rode-Kristensen N, Sardu ML, Smith GR, Swat MJ, Terranova N, Yngman G, Yvon F, Holford N; DDMoRe consortium CPT: Pharmacometrics Syst Pharmacol. 2017
  4. Thoughtflow: Standards and Tools for Provenance Capture and Workflow Definition to Support Model-Informed Drug Discovery and Development. Wilkins JJ, Chan P, Chard J, Smith G, Smith MK, Beer M, Dunn A, Flandorfer C, Franklin C, Gomeni R, Harnisch L, Kaye R, Moodie S, Sardu ML, Wang E, Watson E, Wolstencroft K, Cheung S; DDMoRe Consortium..  CPT: Pharmacometrics Syst Pharmacol. 2017, 5, 285-292
  5. Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development. MJ Swat, S Moodie, SM Wimalaratne, NR Kristensen, M Lavielle, A Mari, P Magni, MK Smith, R Bizzotto, L Pasotti, E Mezzalana, E Comets, C Sarr, N Terranova, E Blaudez, P Chan, J Chard, K Chatel, M Chenel, D Edwards, C Franklin, T Giorgino, M Glont, P Girard, P Grenon, K Harling, AC Hooker, R Kaye, R Keizer, C Kloft, JN Kok, N Kokash, C Laibe, C Laveille, G Lestini, F Mentré, A Munafo, R Nordgren, HB Nyberg, ZP Parra-Guillen, E Plan, B Ribba, G Smith, IF Trocóniz, F Yvon, PA Milligan, L Harnisch, M Karlsson, H Hermjakob and N Le Novère, CPT: Pharmacometrics Syst Pharmacol. 2015, 4, 316-319

Papers related to DDMoRe
Good Practices in Model-Informed Drug Discovery andDevelopment: Practice, Application, and Documentation. EFPIA MID3 Workgroup: SF Marshall, R Burghaus, V Cosson, SYA Cheung, M Chenel, O DellaPasqua, N Frey,B Hamren, L Harnisch, F Ivanow, T Kerbusch, J Lippert, PA Milligan, S Rohou, A Staab, JL Steimer, C Tornøe and SAG Visser CPT: Pharmacometrics & Systems Pharmacology 2016, 5, 93–122

BioModels: expanding horizons to include more modelling approaches and formats. Mihai Glont, Tung V. N. Nguyen, Martin Graesslin, Robert Halke, RazaAli, Jochen Schramm, Sarala M. Wimalaratne, Varun B. Kothamachu, Nicolas Rodriguez, Maciej J. Swat, Jurgen Eils, Roland Eils, Camille Laibe, Rahuman S. Malik-Sheriff, Vijayalakshmi Chelliah, Nicolas Le Novere and Henning Hermjakob Nucleic Acids Research, 2018, Vol. 46 doi: 10.1093/nar/gkx1023

Getting Digital Assets from Public–Private Partnership Research Projects through “The Valley of Death,” and Making Them Sustainable. Wendy Aartsen, Paul Peeters, Scott Wagers and Bryn Williams-Jones.  Front. Med. 2018 5:65. doi: 10.3389/fmed.2018.00065

Skip to toolbar